Connor, Clark & Lunn Investment Management (CC&L)’s Heron Therapeutics HRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-63,371
| Closed | -$158K | – | 1342 |
|
|
2022
Q4 | $158K | Sell |
63,371
-165,240
| -72% | -$413K | ﹤0.01% | 1081 |
|
|
2022
Q3 | $965K | Buy |
+228,611
| New | +$965K | 0.01% | 667 |
|
|
2022
Q2 | – | Sell |
-125,932
| Closed | -$720K | – | 1111 |
|
|
2022
Q1 | $720K | Buy |
+125,932
| New | +$720K | ﹤0.01% | 718 |
|
|
2015
Q2 | – | Sell |
-37,200
| Closed | -$541K | – | 636 |
|
|
2015
Q1 | $541K | Buy |
+37,200
| New | +$541K | ﹤0.01% | 385 |
|